Prospective clinical cohort trial analyzing long-term results after allogeneic stem cell transplantatio

• Conditions: Z94.80; Z94.81

• Registration Number: DRKS00009683
• Lead Sponsor: niversitätsklinikum Greifswald

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-11-25
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

allogeneic stem cell transplantation in Greifswald for hematologic malignancy
- at least 5 year survival after allogeneic stem cell transplantration
- no clinical signs of relapse or progression
- written informed consent

Exclusion Criteria

- none defined

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Description of health status and quality of life as long-term results after allogeneic stem cell transplantation, prevalence of long-term complications

Secondary Outcome Measures

Name	Time	Method
Identifying risk-factors for late complications after allogeneic stem cell transplantion, esp. urological complications